StonvexLoading…
StonvexStonvexStonvexCore line items from CX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | $16.20B | $16.55B | $14.71B | $14.38B |
Operating Income | $1.82B | $1.75B | $873.00M | $1.64B |
Net Income | $960.00M | $199.00M | $885.00M | $778.00M |
EPS (Diluted) | $0.02 | $0.00 | $0.02 | $0.02 |
Total Assets | $27.30B | $28.43B | $26.45B | $26.65B |
Total Liabilities | $14.82B | $16.32B | $15.54B | $16.38B |
Cash & Equivalents | $864.00M | $624.00M | $495.00M | $613.00M |
Free Cash Flow OCF − CapEx | $894.00M | $1.36B | $613.00M | $1.07B |
Shares Outstanding | Not available | Not available | Not available | Not available |